SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-042952
Filing Date
2024-04-09
Accepted
2024-04-09 16:01:51
Documents
75
Period of Report
2024-02-29

Document Format Files

Seq Description Document Type Size
1 10-Q neog-20240229.htm   iXBRL 10-Q 2323378
2 EX-31.1 neog-ex31_1.htm EX-31.1 13766
3 EX-31.2 neog-ex31_2.htm EX-31.2 13581
4 EX-32 neog-ex32.htm EX-32 11110
  Complete submission text file 0000950170-24-042952.txt   10214605

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20240229.xsd EX-101.SCH 1646326
79 EXTRACTED XBRL INSTANCE DOCUMENT neog-20240229_htm.xml XML 1860312
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-17988 | Film No.: 24832675
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)